About Index Trending news
Analyze
Pricing
Frazier Healthcare

Frazier Healthcare

Work at Frazier Healthcare? Add yourself to this profile

Frazier Healthcare

Growth Capital for Healthcare Companies
Edit Profile
More info

Elsewhere

Also headquartered in Seattle

Amazon Amazon GeekWire GeekWire Zillow Zillow Starbucks Starbucks Redfin Redfin Tableau Tableau Seattle Seattle Wagon Wagon Startup Weekend Startup Weekend Bungie Bungie

Companies in the same industry

Defrag/Glue Defrag/Glue Chrysalis Ventures Chrysalis Ventures Dioko Health Ventures Dioko Health Ventures Cinven Cinven RoundGlass RoundGlass Education Growth Partners Education Growth Partners NaviMed Capital NaviMed Capital T2 Capital Management T2 Capital Management AngelList AngelList Healthbox Healthbox

Alexa global traffic share

Twitter followers

Terms of Service API Integrations Plans & Pricing
Built with ❤︎ by Datalicious ©2017
A daughter company of TNW.
Index.co is not affiliated with Index Ventures.

Overview

Investments 38

Portfolio

Portfolio tracker
Add info

Investment profile

Target markets
Health Care Biotechnology Therapeutics

Activity

Past year's investments

- Frazier Healthcare Partners participated in 3 rounds in the past year.
- The total disclosed amount of capital deployed in those rounds was $165,000,000 (averaging $55,000,000 per round).

Latest rounds

- Iterum Therapeutics: Venture capital (Series B) ($65M)
- Cirius Therapeutics: Venture capital (Series A) ($40M)
- SutroVax: Venture capital (Series B) ($60M)

Main Co-investors

- Domain Associates
- 5AM Ventures
- Versant Ventures

Chimerix

Chimerix

Health Care +1
Total funding
$217.2M in 5 rounds from 14 investors
By Frazier Healthcare Partners
$23.1M Series D in Feb, 2007
Merganser Biotech, Inc.

Merganser Biotech, Inc.

Biotechnology
Total funding
$28M in 1 rounds from 5 investors
By Frazier Healthcare Partners
$28M Series A in Feb, 2015
PatientKeeper

PatientKeeper

Software
Total funding
$83.8M in 6 rounds from 24 investors
By Frazier Healthcare Partners
$7.5M Venture capital in Aug, 2008
Zeltiq

Zeltiq

Medical Devices +1
Total funding
$70.4M in 3 rounds from 7 investors
By Frazier Healthcare Partners
$25M Series D in Jun, 2010
Exit Allergan plc, Feb 13, 2017
Stemgent

Stemgent

Biotechnology
Total funding
$16.7M in 2 rounds from 4 investors
By Frazier Healthcare Partners
$14M Series B in Mar, 2009
Stromedix

Stromedix

Biotechnology
Total funding
$26M in 2 rounds from 7 investors
By Frazier Healthcare Partners
$25M Series B in Apr, 2008
Clovis Oncology

Clovis Oncology

Health Care +1
Total funding
$145M in 1 rounds from 7 investors
By Frazier Healthcare Partners
$145M Private equity in May, 2009
Portola Pharma

Portola Pharma

Biotechnology
Total funding
$149.1M in 2 rounds from 20 investors
By Frazier Healthcare Partners
$60.1M Series C in Jun, 2009
Achaogen

Achaogen

Health Care +1
Total funding
$116.6M in 4 rounds from 20 investors
By Frazier Healthcare Partners
$18.9M Series D in Mar, 2013
ZONARE Medical Systems, Inc.

ZONARE Medical Systems, Inc.

Health Care
Total funding
$64M in 2 rounds from 16 investors
By Frazier Healthcare Partners
$30M Venture capital in Feb, 2008
AnaptysBio

AnaptysBio

Biotechnology
Total funding
$110M in 3 rounds from 8 investors
By Frazier Healthcare Partners
$33M Series B in Nov, 2007
Zavante Therapeutics, Inc.

Zavante Therapeutics, Inc.

Medical +2
Total funding
$65M in 3 rounds from 5 investors
By Frazier Healthcare Partners
$45M Series A in Mar, 2016
Glaukos Corporation

Glaukos Corporation

Health Care
Total funding
$75M in 3 rounds from 17 investors
By Frazier Healthcare Partners
$30M Series F in Feb, 2013
BARRX Medical

BARRX Medical

Technology +2
Total funding
$15M in 1 rounds from 6 investors
By Frazier Healthcare Partners
$15M Series D in Jul, 2010
VentiRx Pharmaceuticals

VentiRx Pharmaceuticals

Health Care +2
Total funding
$50.6M in 1 rounds from 5 investors
By Frazier Healthcare Partners
$50.6M Series B in Sep, 2014
Millendo Therapeutics

Millendo Therapeutics

Biotechnology
Total funding
$62M in 1 rounds from 9 investors
By Frazier Healthcare Partners
$62M Series B in Jan, 2016
SutroVax

SutroVax

Health Care +2
Total funding
$82M in 2 rounds from 10 investors
By Frazier Healthcare Partners
$60M Series B in Mar, 2017
Cidara Therapeutics

Cidara Therapeutics

Health Care +2
Total funding
$100.9M in 4 rounds from 16 investors
By Frazier Healthcare Partners
$42M Series B in Feb, 2015
Outpost Medicine

Outpost Medicine

Biotechnology +1
Total funding
$41M in 1 rounds from 5 investors
By Frazier Healthcare Partners
$41M Series A in Mar, 2016
Iterum Therapeutics

Iterum Therapeutics

Therapeutics
Total funding
$105M in 2 rounds from 13 investors
By Frazier Healthcare Partners
$65M Series B in May, 2017
Entasis Therapeutics

Entasis Therapeutics

Biotechnology
Total funding
$50M in 1 rounds from 5 investors
By Frazier Healthcare Partners
$50M Series B in Apr, 2016
Aptinyx Inc.

Aptinyx Inc.

Health Care +1
Total funding
$65M in 1 rounds from 10 investors
By Frazier Healthcare Partners
$65M Series A in May, 2016
Lion Biotechnologies

Lion Biotechnologies

Medical +2
Total funding
$100M in 1 rounds from 4 investors
By Frazier Healthcare Partners
$100M Post-IPO equity in Jun, 2016
Alpine Immune Sciences

Alpine Immune Sciences

Biotechnology
Total funding
$96M in 2 rounds from 6 investors
By Frazier Healthcare Partners
$48M Series A in Jun, 2016
Cirius Therapeutics

Cirius Therapeutics

Medical +1
Total funding
$40M in 1 rounds from 2 investors
By Frazier Healthcare Partners
$40M Series A in Apr, 2017

Want to see the complete list?
Go Pro!